000 | 01194 a2200337 4500 | ||
---|---|---|---|
005 | 20250518081157.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a1948-5875 | ||
024 | 7 |
_a10.1021/acsmedchemlett.9b00471 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShouksmith, Andrew E | |
245 | 0 | 0 |
_aClass I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia. _h[electronic resource] |
260 |
_bACS medicinal chemistry letters _cJan 2020 |
||
300 |
_a56-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aGawel, Justyna M | |
700 | 1 | _aNawar, Nabanita | |
700 | 1 | _aSina, Diana | |
700 | 1 | _aRaouf, Yasir S | |
700 | 1 | _aBukhari, Shazreh | |
700 | 1 | _aHe, Liying | |
700 | 1 | _aJohns, Alexandra E | |
700 | 1 | _aManaswiyoungkul, Pimyupa | |
700 | 1 | _aOlaoye, Olasunkanmi O | |
700 | 1 | _aCabral, Aaron D | |
700 | 1 | _aSedighi, Abootaleb | |
700 | 1 | _ade Araujo, Elvin D | |
700 | 1 | _aGunning, Patrick T | |
773 | 0 |
_tACS medicinal chemistry letters _gvol. 11 _gno. 1 _gp. 56-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/acsmedchemlett.9b00471 _zAvailable from publisher's website |
999 |
_c30519369 _d30519369 |